Autoimmunity in Retinitis Pigmentosa
1 other identifier
interventional
N/A
1 country
1
Brief Summary
Using local immune suppression, the trial seeks evidence for the hypothesis that autoimmunity plays a role in the pathomechanism of retinitis pigmentosa.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 6, 2007
CompletedFirst Posted
Study publicly available on registry
February 9, 2007
CompletedFebruary 9, 2007
February 1, 2007
February 6, 2007
February 8, 2007
Conditions
Interventions
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of retinitis pigmentosa
You may not qualify if:
- Cataract
- Extremely low ERG wave amplitude (less than 8% of normal)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Semmelweis University, Dept. of Ophthalmology
Budapest, H-1085, Hungary
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Zoltán Z. Nagy, M.D.
Semmelweis University, Dept. of Ophthalmology
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
February 6, 2007
First Posted
February 9, 2007
Last Updated
February 9, 2007
Record last verified: 2007-02